UnitedHealth Group Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? UnitedHealth Group Inc trades at $378.24 (market cap $332.96B), while Vanguard Total World Stock Index Fund ETF trades at $159.73 (market cap $101.70B). The key difference: UnitedHealth Group Inc is far larger — about 3.3× Vanguard Total World Stock Index Fund ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Vanguard Total World Stock Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and Vanguard Total World Stock Index Fund ETF for 53 Days on average.
| UNH | VT | |
|---|---|---|
Market Cap | $332.96B | $101.70B |
Volume | 7,273,749 | 1,783,794 |
Sector | Health | Broad Market / Factor |
52-Week High | $436.35 | $162.39 |
52-Week Low | $259.02 | $134.19 |
Typical Hold Time | 97 Days | 53 Days |
Enterprise Value | $374.82B | — |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.
The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.
VT, the Vanguard Total World Stock ETF, trades at $159.39, down 0.16% on the day. Technical indicators show a bearish bias with moving averages signaling selling pressure, while oscillators remain neutral. The ETF offers broad global diversification with over 9,700 stocks and a low expense ratio of 0.06%, though key valuation ratios like P/E and P/B are not disclosed in the provided data. Recent news highlights its role as a core holding for long-term investors seeking worldwide exposure.
The outlook for VT is supported by its cost efficiency and diversification benefits, but near-term technical weakness and competitive pressures from lower-fee alternatives pose risks. Investor sentiment is mixed, with some analysts favoring VT for its comprehensive coverage, while others point to higher expenses relative to peers. Macroeconomic uncertainties and trade tensions could impact global equity returns, affecting VT's performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →